📰 Mark Lebwohl News
Page 2 - Mark Lebwohl News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Lebwohl. Real-time updates on events, politics, business and more.
April 7, 2023
/PRNewswire/ -- On Tuesday evening, at The Plaza, American Skin Association (ASA) held their Spring Gala, where they presented awards to two outstanding...
February 9, 2023
Phase 2 results show a reduction in itch in patients with notalgia paresthetica, but 19% of patients discontinued the trial because of side effects compared with 6% in the placebo group.
February 9, 2023
New York, NY (PRWEB) February 09, 2023 -- Notalgia paresthetica—a nerve disorder characterized by a persistent itch in the upper back—is a common and
January 14, 2023
During the open label trial, 57.1% of roflumilast-treated participants achieved Investigator Global Assessment (IGA) of clear or almost clear at any time...
October 13, 2022
- Five posters will highlight clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and for atopic dermatitis in patients as young as two - Dermavant Sciences, a biopharmaceutical
October 10, 2022
What is psoriasis? We take a deep look at the signs and symptoms of this itchy disease. Plus, Anthony Fernandez, MD, PhD, offers more insight on causes and treatments.
September 10, 2022
Results add to the growing body of evidence and reinforce the efficacy profile of Sotyktu, a once-daily, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of moderate-to-severe plaque psoriasisNew analysis to be presented at the 2022 European Academy of Dermatology and Venereology Cong...
September 7, 2022
Spesolimab led to complete clearance of pustules within a week in more than half of patients
September 2, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
September 2, 2022
More than half of patients treated with SPEVIGO® (spesolimab-sbzo) injection, for intravenous use showed no visible pustules one week after receiv...